Clinical trials
Malnutrition trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 10 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bispebjerg Hospital | 6 |
| University of Aarhus | 6 |
| University of Copenhagen | 6 |
| Copenhagen University Hospital at Herlev | 4 |
| Herlev Hospital | 4 |
| Hvidovre University Hospital | 4 |
| Jens Rikardt Andersen | 3 |
| Gødstrup Hospital | 2 |
| Christian Hvas | 1 |
| Herlev and Gentofte Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malnutrition | 41 |
| Inflammation | 4 |
| Weight Loss | 4 |
| Emergencies | 3 |
| Neoplasms | 3 |
| Obesity | 3 |
| Sarcopenia | 3 |
| Lung Diseases | 2 |
| Lung Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
Trials
Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.